Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
17:17:56 EDT Thu 18 Apr 2024
Enter Symbol
or Name
USA
CA



Q:AMGN - AMGEN INC - http://www.amgen.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
AMGN - Q0.2262.95·265.440.2262.75-1.32-0.52,082.2546,66328,210264.10  265.92  262.58329.72  211.7116:49:18Apr 1615 min RT 2¢

Recent Trades - Last 10 of 28210
Time ETExPriceChangeVolume
16:49:18Q262.80-1.271
16:48:09Q263.14-0.9316
16:48:09Q262.79-1.28100
16:48:09Q262.79-1.2828
16:44:05Q263.00-1.07101
16:43:53Q262.75-1.3225,000
16:31:45Q262.75-1.3273,000
16:28:17Q262.75-1.322
16:21:12Q264.00-0.077
16:15:03Q262.75-1.321

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-16 17:26U:AMGNNews ReleaseAMGEN TO PRESENT TEZSPIRE(TM) PHASE 2A COPD DATA AT ATS 2024
2024-03-09 12:20U:AMGNNews ReleaseAMGEN PRESENTS NEW RESEARCH ON OTEZLA(TM) (APREMILAST) AT AAD 2024
2024-03-06 16:00U:AMGNNews ReleaseAMGEN ANNOUNCES 2024 SECOND QUARTER DIVIDEND
2024-02-29 16:00U:AMGNNews ReleaseAMGEN TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTH CARE CONFERENCE
2024-02-26 09:00U:AMGNNews ReleaseAMGEN OPENS STATE-OF-THE-ART BIOMANUFACTURING SITE IN CENTRAL OHIO
2024-02-19 16:00U:AMGNNews ReleaseAMGEN TO HOST CONFERENCE CALL ON RARE DISEASE
2024-02-09 16:00U:AMGNNews ReleaseAMGEN TO PRESENT AT THE 34TH ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE
2024-02-06 16:01U:AMGNNews ReleaseAMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS
2024-02-01 16:00U:AMGNNews ReleaseAMGEN ANNOUNCES WEBCAST OF 2023 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS
2024-01-29 05:00U:AMGNNews ReleasedeCODE genetics: A sequence variant that increases risk of pregnancy loss
2024-01-09 10:25U:AMGNNews ReleaseGlobal Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
2024-01-03 16:00U:AMGNNews ReleaseAMGEN TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
2023-12-26 09:00U:AMGNNews ReleaseAMGEN PROVIDES REGULATORY UPDATE ON STATUS OF LUMAKRAS ‚ ® (SOTORASIB)
2023-12-14 09:00U:AMGNNews ReleaseAMGEN ANNOUNCES EXECUTIVE APPOINTMENTS TO ACCELERATE INNOVATION
2023-12-14 05:00U:AMGNNews ReleaseAMGEN TO SPONSOR THE IRISH OPEN
2023-12-13 16:00U:AMGNNews ReleaseFDA Grants Priority Review to Amgen's Tarlatamab Application for Advanced Small Cell Lung Cancer
2023-12-12 16:00U:AMGNNews ReleaseAMGEN ANNOUNCES 2024 FIRST QUARTER DIVIDEND INCREASE TO $2.25 PER SHARE
2023-12-08 09:00U:AMGNNews ReleaseAMGEN HIGHLIGHTS HEMATOLOGY PORTFOLIO AT ASH 2023
2023-11-22 16:00U:AMGNNews ReleaseAMGEN TO PRESENT AT THE EVERCORE ISI HEALTHCONX CONFERENCE